Upcoming Events

Organizing successful conferences has been at the core of ConferenceSeries LLC Ltd. We are delighted to organize the International Conference on Biological & Pharmaceutical Sciences during November 19-20, 2018 at Sydney, Australia.

The conference is a specially organized two-day event which will provide a multi-channel communication platform that brings together both “producers” and “consumers” of pharma & biological science world of generic sector. It includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. It is a perfect platform for researchers, scientists and, delegates to share experience, foster collaborations across industry and academia, and evaluate emerging technologies across the globe.

Precision medicine aims to individualise therapeutic interventions, based on OMICS data such as genomics, proteomics, metabolomics etc’, profiling together with histopathological insights to the type, stage, and the grade of the disease, as well as on the potential response of a particular patient to a particular treatment regimen. With next generation sequencing technologies, it is now possible to identify all germline variants of an individual at an affordable cost and thus paving the way for clinicians to provide healthcare from an individual perspective. However, the data that correlate specific disease type, response to specific treatment, and adverse effects as a result of the treatment, are slow to come. There are also critical voices warning us of getting lost in Big Data and advocating a stronger role of physiological models and phenotypic data in drug R&D. Another dimension of this debate is related to the way many companies manage their precision medicine processes and strategies for developing a more agile approach in the field.

The summit on “Controversies in Precision Medicine - Designer Genes for Health”, under the leadership of Professor Dan Peer, Director of Tel Aviv University Cancer Biology Research Center and Translational Medicine, will explore these debates and facilitate discussions on future ways to increase the productivity of biopharmaceutical and clinical innovation.

Pharmtech & Ingredients is the largest exhibition of equipment, raw materials and technologies for pharmaceutical production in Russia and the EEU countries.

    Visitors -  7 546
    Exhibitors - 401 companies from 30 countries
    Total exhibition space –  > 16 500 sq.m
    National expositions

*Statistics of 2017

Exhibition topics:

•    Equipment for pharmaceutical production
•    Packaging equipment and materials
•    Laboratory equipment and materials
•    Clean room technology
•    Turnkey projects/Engineering
•    Pharmaceutical raw materials and ingredients
•    Contract manufacturing services

Conference Series is proud to host the 8th World congress on Rare Diseases & Orphan Drugs (Euro Orphan Drugs 2018) during November 21-22, 2018 at Paris-France. This upcoming European Orphan Drug Conference is designed on the theme “Challenges & Opportunities in Orphan Drugs Development: Commercialisation, Policies, Reimbursement, and Pricing “.

This Rare Diseases & Orphan Drugs Conference aims to provide the best platform to all the researchers working in Rare Diseases & Orphan Drugs Research, Orphan Drugs developers, Healthcare sector, regulatory & health authorities, patient organisations, patient advocacy, Clinical Trials & Research, and public policy individuals.

This Orphan Drugs & Rare Diseases Congress 2018 Europe will offer a proper platform will provide a unique platform for all the stakeholders in the Orphan Drug Industry sector to discuss current issues, trends and innovations in Rare Diseases Research & Orphan Drugs development and to network with hospitals, Research labs, Pharma-Biopharma Companies, Orphan Drugs developers, and non-profit organizations etc.

This Orphan Drugs Congress 2018 composed of extended scientific sessions, Plenary sessions, Oral Presentations, Industry oriented sessions, Poster Presentations, Exhibitor sessions, Workshops, Symposiums, Young Research Forums, Videos Presentations and e-Poster Presentations etc.

Conference Series llc Ltd welcomes all the Clinical Researchers and policy makers to attend the upcoming 8th World congress on Clinical Trials & Regulatory Affairs (WCT-2018), during November 21-22, 2018 Paris, France. This upcoming Clinical Trials Conference in Paris is based on the theme “Current challenges in Clinical Trials: From Trials Design to Regulatory Framework”.

This World Clinical Trials Conference invite the broad range stakeholders ranging from Clinical researchers, Clinical research investigators, Physicians, CROs, Clinical Research Sponsors (both Industry, Academia, Government bodies, Non-profit Organizations), patients, patient advocates, payers, regulators and Clinical Researchers from hospitals, health systems providers etc including other essentials components of Clinical Trials and Clinical Researches.

All the stakeholders of the Clinical Trials and Clinical Research joined together in this platform to discuss the challenges the clinical research industry is facing starting from patient requirements to Clinical Trials Design, Adaptation of technology to Clinical Trials Data Collection and Regulatory Challenges to the cost associated with the Clinical Trials. Major Challenges the Clinical Research Industry facing include: Complexity of Trials, Regulatory framework, Spiralling Costs, Technology, Patient Access, Clinical Research Staff roles and Responsibilities, Challenges in strategic partnership building between stakeholders and discovery of New Drugs etc.

This Clinical Trials and Clinical Research Congress (WCT-2018) composed of well organized scientific sessions, Plenary Presentations, Industry oriented sessions, Oral Presentations, Poster Presentations, Exhibitor Presentations, Workshops, Symposiums, round table discussions, Young Research Forums, Videos Presentations and e-Poster Presentations etc. This Clinical Trials & Regulatory affairs Congress is the part of the Pharmaceutical Conferences organized by Conference Series LLC Ltd.

The 21st MEDEXPO 2018 - International Trade Exhibition is the largest trade event held annually in Tanzania, concurrently held with East Africa Trade Exhibition (EAITE).The exhibition attracts exhibitors from more than 20 countries and visitors from all over East & Central Africa, thus giving exhibitors an excellent opportunity to explore several countries at one time. Over the past few years, Tanzania has emerged as a major regional trade centre. This is mainly due to the very friendly and businesslike atmosphere it offers to foreign investors and products. Duties are considerably low and re-exports to neighboring countries are either very low or exempted.

The 2018 event will cover:

    The latest supply chain management technologies and innovations
    Agile customer-centric supply planning and optimisation strategies
    Transparency, control and synchronisation across all manufacturing and supply chain operations, including production, quality, labour, maintenance and material flows
    Risk and volatility management in a global economy
    Disruptive technologies for managing supply, production and delivery; big data, IoT and smart manufacturing
    The use of analytics to interpret complexity demand information in omni-channel market
    Working across silos: realising the synergies and maximising the opportunities

As Conference Chairman I have the privilege of inviting you to the 11th HIS International Conference.  HIS 2018 will be an invaluable source of education, inspiration and networking opportunities and I very much hope you’ll be able to join us at the Arena and Convention Centre (ACC) Liverpool, UK in November 2018.

Our aim is to build on the success of our previous conference at which 93% of delegates rated the scientific content as very good or good and 95% said their overall conference experience was very good or good.

If you are a healthcare professional with an interest in any aspect of healthcare associated infection then you will benefit from attending this event.  Some of the world’s leading experts will be in attendance to impart their knowledge and share what they’re doing to tackle current issues relating to infection prevention and control.

SMi Group are proud to present the 2nd Annual Ophthalmic Drugs Conference on 26th - 27th November 2018, London, United Kingdom.
 
As the global population ages, the incidence of ophthalmic disorders continues to grow, and thus the interest of pharmaceutical and biotech companies is increasingly focused towards innovation of novel approaches for the development of ophthalmic drugs, driving the growth of this market. In fact, the global ophthalmic drug market is projected to reach £30 billion by 2023, growing at a CAGR of 5.3% from 2017 to 2023 (Via *Allied Market Research)

Join industry experts from Roche, Santen, Aerie Pharmaceuticals, MHRA, Nightstar Therapeutics and more to discuss and analyze the latest advancements and challenges within ophthalmic drug development. Network with industry professionals, explore novel approaches to treatment of ocular diseases, gain insight into ongoing clinical trials, discover how technology is revolutionising pharmaceutical R&D, and get invaluable advice on how to enhance development and overcome challenges within the industry.

Rather than covering a random selection of immuno-oncology combinations, 4th Annual ICI Europe Summit focuses on how checkpoint combinations can impact every stage of the cancer immunity cycle, enhancing the long-term success of immuno-oncology drug development.

Cutting through the noise and hype around the immuno-oncology field, this industry focused conference will use the cancer immunity cycle as a framework from which to investigate the most promising immuno-oncology approaches.

The MENA pharmaceutical market has recorded significant growth in the past few years, as a result of increased spending power, growth of aging population, and lifestyle associated diseases.

Eventually, the total demand for pharmaceutical products has reached the highest levels in some of the MENA countries, and the pharmaceutical products sales are expected to grow massively in the upcoming years.

Hence, many governments in the region have started encouraging more investments in the local pharmaceutical manufacturing, either through building new pharmaceutical industrial areas, or through attracting more foreign direct investment. Some of the biggest European and American Pharmaceutical companies have ongoing projects establishing new pharmaceutical plants in the MENA region, including Saudi Arabia which is expected to be the leading pharma manufacturing hub in the region.

That’s why the MENA Pharmaceutical Manufacturing Congress, will set a unique platform by gathering the pioneers from the local and international pharmaceutical companies; CEOs, plant managers, production managers, supply chain managers, quality assurance managers, regulators affairs managers, and engineers. In addition to the leading technology providers who will showcase the latest technologies and developments in pharmaceutical manufacturing.

The congress will include case studies, presentations, and interactive panel discussions which will focus on issues like the obstacles fronting the pharmaceutical industry, the integration between the different concerned entities, and the future of the industry in the region.

The Saudi healthcare system has made extraordinary progress within a short period of time, where there is a huge investment to provide high quality health care to patients moving to a patient-centric model where pharmacists play a vital role as integral members of the healthcare team.

Pharmacists play an important role as leaders to improve healthcare outcomes, reduce cost, enhance patient safety, optimise medication management systems, and align the pharmacy services with the management strategies that measure and reward quality performance. However, the continuous evolution of pharmacist’s role is tied to numerous challenges including collaboration with the different stakeholders in the medical community, learning about new technologies, remaining competitive in the marketplace, improving patient outcomes, maintaining productivity and more. The Arab International Pharmacy Congress will familiarise attendees with the latest technologies used to improve healthcare outcomes, highlight key solutions to the challenges, facing the profession in the kingdom and covers a variety of topics enhancing supply chain management, ambulatory and clinical pharmacy practice, medication safety, pharmacy informatics and more. The Congress will feature interactive case studies, presentations, educational workshops and ample networking opportunities to discuss the main problems encountered during practice.

The dermatology space continues to strive in therapeutic innovation. There’s been a transformative evolution in the understanding of the pathophysiology of skin diseases, and in the available treatment options for chronic, moderate to severe dermatological conditions that affect lives of millions of patients worldwide.

The 2nd annual Dermatology Drug Development Summit provides a unique forum for industry leaders to take advantage of this tremendous environment of opportunity driven by huge investments to innovate and bring better and more efficient drugs to market, for the treatment of high unmet need.

Saudi Arabia is one of the fastest growing markets in the region and as new economic cities are growing within the Kingdom, Saudi Arabia’s logistics sector is poised for significant expansion.

According to a recent industry report, the Saudi Arabian logistics and warehousing sector is set to witness a considerable boom, driven by the Saudi government’s push to expand the industrial sector’s contribution to the economy to 20 per cent by 2020, up from the current 10 per cent level.

With further diversification in the economy and a host of massive infrastructure projects currently including a high speed rail network and new airports under construction, coupled with a projected population growth to the tune of 31 million by 2020 presents plenty of new opportunities for the supply chain and logistics sector in the coming years in Saudi Arabia.

It is against this dynamic background that we are organising the Supply Chain and Logistics Forum in the Kingdom as a part of Materials Handling Saudi Arabia Exhibition. The two day forum which will be held on 28 – 29 November 2018 at the Park Hyatt in Jeddah will feature critical discussions and debates that will explore the future directions of the global supply chain industry, and new trends and changing dynamics of the industry in the region.

Executive and administrative assistants are an essential part of the support system for the leadership of any organization. They add value to their organization through strategic and creative approaches to internal and external communication on behalf of their company’s leadership. Whether they are training a group of new support staff, coaching a C-level executive assistant to navigate complex communications, facilitating a dynamic workshop, teaching leadership how to utilize their assistants for maximum benefit these member of an organization are a crucial part of daily operations. Administrative professionals frequently wear many hats and are often tasked with keeping track of budgets and ensuring adherence to the funds they’ve been allocated.

As more pharmaceutical and biotechnology companies grow to meet medical needs on a global scale, the role of the administrative professional has never been more critical than in today’s dynamic drug development sector. This event will allow executive support staff in the life science industry to gather for a unique opportunity to share communication and organization strategies that enable them to support some of the most influential thought leaders in the pharmaceutical industry.

Oncology Drug Development in Practice (ODDP) is an educational program designed for professionals in academia and industry who wish to acquire or expand their knowledge of drug development in oncology.

CBI’s Digital Therapeutics will bring together the senior stakeholders developing groundbreaking treatments to collaborate to chart a path forward for broad adoption of next generation therapies. This year’s event will allow you to convene with industry thought leaders to overcome regulatory, development, software, business and legal challenges to ensure cutting edge treatments become commonplace.

Cenetri Publishing Group looks forward to welcome all the participants across the Globe to attend "World Congress on Rare Diseases and Orphan Drugs 2018" which includes prompt Keynote Presentations, Special Sessions, Workshops, Symposiums, Oral talks, Poster Presentations and Exhibitions.

The conference highlights the theme: "Novel Technologies and Innovations for treatment of Rare Diseases". On behalf of the organizing committee, we are delighted to announce that the World Congress on Rare Diseases and Orphan Drugs (RDOD 2018) will be held from December 03 - 05 in Budapest, Hungary. RDOD 2018 delivers a premier interdisciplinary platform for researchers to present the cutting-edge research findings and define emerging technologies, hear from the experts and join the conversation in rare diseases and orphan drugs issues.

Digital Therapeutics are storming into the healthcare mainstream, offering a novel and effective way of preventing and treating some of the world’s most medically unmet and chronic disease conditions. The inaugural Clinically Validated Digital Therapeutics Summit 2018 is a dedicated scientific and networking forum for pharmaceutical, biotech and healthcare pioneers to capitalize on this emerging therapeutic class.

The 1st RNA Targeted Drug Discovery Summit is dedicated to help you successfully identify, target and validate RNA targets, and better overcome the chemistry challenges of designing small molecules.

As the potential to drug the RNA increases, a plethora of previously un-druggable targets are opening up. Curated with the insights from those leading the push in Pharma, Biotech & Academia, the RNA Targeted Drug discovery Summit is devoted to optimizing the process of discovering small molecules that bind specifically to quality RNA targets and translating these into clinically effective therapies.

The Annual Global Supply Chain Innovation Leaders Summit (SCIS) is an executive gathering dedicated to being a new catalyst for innovation. Bringing together the greatest minds to illuminate key pain points across the supply chain and packaging industry, improve partnerships, planning and performance, decision making, process cost-efficiency, packaging compliance, automation, temperature control, serialisation, and much more.

Gathering up to 150 high-level decision-makers in the biological and pharmaceutical industry and showcasing speakers & thought leaders across pivotal sectors to give depth & insight.

Network and benchmark through influential keynote talks, engaging panel discussions, networking dinners and lunches, as well as pre-scheduled and pre-qualified meetings.

The 3rd Healthcare Ad-Tech & Programmatic Strategy Summit is designed for advertising, marketing, digital and branding professionals from health systems, pharmaceutical companies, insurance providers, drug manufacturers, pharmacies, publishers, and agencies to gather and discuss common challenges in the implementation of digital innovations.

Join us for this two-day educational event to learn top strategies for enhancing your audience engagement and virtual advertising and network with leading marketers, industry professionals, and decision-makers to collaborate on joint ventures.

The annual Global Supply Chain Innovation Leaders Summit (SCIS) is an executive gathering dedicated to being a new catalyst for innovation. Bringing together the greatest minds to illuminate key pain points across the supply chain and packaging industry, improve partnerships, planning and performance, decision making, process cost-efficiency, packaging compliance, automation, temperature control, serialisation, and much more. Gathering up to 150 high-level decision makers in the biological and pharmaceutical industry and showcasing speakers & thought leaders across key sectors to give depth & insight. Network and benchmark through influential keynote talks, engaging panel discussions, networking dinners and lunches, as well as pre-scheduled and pre-qualified meetings.

The Digital Pharma Multichannel Marketing Boot Camp uses a combination of lectures, class discussions and hands-on exercises with people who want to understand how to create effective and sophisticated digital and multichannel marketing (MCM) strategies. This intensive two-day program not only teaches you strategic processes, it also gives you the tools and skills you need to gather insights and develop your own digital and multichannel programs.

Tumour Models London returns for its 7th year and takes a reinvigorated approach towards closing the translational gap between predictable preclinical validation and successful clinical development.

The meeting will dive into how emerging and classical model systems continue to evolve the early-stage decision making to more effectively support the translation from bench to patient.

With new speakers, fresh case studies, and a more interactive format to the meeting agenda, Tumour Models London remains the leading forum for translational and preclinical scientists to really challenge how we optimise IO and Oncology-based research.

Arena International is thrilled to announce that the 4th Clinical Trial Supply East Asia conference is returning to Seoul, 5th – 6th December 2018; the only clinical event focusing on end to end clinical supplies with in cooperating with clinical operations in Asia region.

This conference addresses how companies can effectively streamline clinical supply process to ensure timely and cost-effective clinical studies and be responsive to industry trends to enable early market penetration.

This conference offers great opportunity for delegates to network with industry professionals and service providers, as well as attending insightful lectures from experienced clinicians in East Asia area.

We invite you to join us in December 2018, register your place today.

Arena International is excited to announce that the 4th Outsourcing in Clinical Trial East Asia conference is returning to Seoul, 5th – 6th December 2018 with tailored topics to local trial sponsors.

This conference addresses how companies can effectively planning Multiregional Clinical Trials in light of changing regulations in East Asia region and sourcing local/global vendors according to study purpose and be responsive to industry trends to enable early market penetration.

This conference offers great opportunity for delegates to network with industry professionals and service providers, as well as attending insightful lectures from experienced clinicians in East Asia area.

With Immense pleasure, Pharma Congress 2018 along with the Organizing Committee Members invites all the participants from all across the globe to attend 3rd International Conference on Pharmaceutics and Novel Drug Delivery Technology which is slated on December 05-06, 2018 at Dubai, UAE with the theme New Paradigm and innovations in Pharmaceutics and Novel Drug delivery technology. Pharma Congress 2018 offers an excellent platform for the interaction amongst experts, administrators, Professors, faculties, professionals, and studies fellows round the arena reputed studies institutes, universities and companies, agencies, affiliation & societies and mainly accelerating the clinical discoveries inside the subject of Pharmaceutics and Novel Drug transport structures to trade statistics at the contemporary studies progress.

CBI’s 2nd Annual MEDICAL WRITERS SUMMIT is the go-to event to connect with fellow medical writers and industry thought leaders in an unmatched educational setting to dive into the high-level and specific challenges that the medical writing community faces. Featuring a diverse and highly experienced speaking faculty, participants at this summit walk away with fresh insight on best practices, whether you are a new or a veteran writer.

Join with peers to learn and exchange expertise in key areas, including project management practices, overcoming roadblocks, cross-functional relationship building, outsourced medical writing, establishing achievable deliverable timelines and much more.

All health components will come together at CNR Expo Yesilköy between 5-8 December 2018 during Istanbul Health Expo - 6th Medical Equipment and Health Services Exhibition, 4th International Integrated Health Care Congress.

The Health Expo Istanbul held yearly with the aim to create added value both to the health sector, and to our economy will take place once again with the full support of the Republic of Turkey Ministry of Health, Turkish Medicine and Medical Devices Agency, SGK (Social Security Institution), and Republic of Turkey Ministry of Family and Social Policies. The exhibition bringing together high-level officials and managers who give direction to the industry will also host the most comprehensive health congress of Turkey simultaneously. Over 200 academics in more than 50 sessions will discuss topics that will contribute to the development of the healthcare sector at the International Integrated Health Care Congress that will be taking place for the 4th time this year.

Participants in the exhibition uniting all the stakeholders in the sector will have the opportunity to establish close contact with public institutions of the health industry. The exhibitors will come together with senior bureaucrats, buyers, physicians, academics and NGOs operating in the industry.

The exhibition will welcome medical device and material buyers from 20 countries, including Saudi Arabia, Qatar, Kosovo, Jordan, Lebanon, Iran, and Iraq.

CBI’s Analytical Development for Biologics conference is singularly focused on state of the art bioanalytics and how the field must evolve to keep pace with current and emerging therapies. Join your peers and colleagues to advance and streamline analytical development.

GDPR has affected the way all business store, manage and communicate with their customers. This is no different from life science organizations who typically have more personal information than other types of organizations. GDPR was designed to better protect the personal data of individuals within the EU and set a precedent for data privacy and security. The regulation provides policGDPRy around any data that can be used to directly or indirectly identify a person, such as their name, photos, email addresses, bank details, posts on social networking websites, medical information, or a computer IP address.

For more than 10 years, industry experts from pharmaceutical, biotech, and academic organizations — in addition to clinical research organizations and investigator sites — have depended on ExL Events’ Clinical Performance Metrics Series to gain proven strategies that enhance performance and improve quality in clinical trials. More than 500 industry professionals have walked away from this summit with the skills and knowledge needed to implement a sustainable, cross-functional approach to metrics in drug and medical device development.This December, come see for yourself why ExL’s Clinical Performance Metrics Series has dominated this space for 15 years. Key leaders assemble to divulge their best practices for adhering to regulatory guidance, leveraging data from past trials to define performance and process metrics that improve present and future clinical trials, decreasing error and variability through improved processes based on root cause analysis, and more! Clinical trials and their performance metrics have continued to evolve and grow, and so has ExL’s Clinical Performance Metrics Series. We look forward to seeing you in December!

India is surging positively on the great strides of development which can be continued only if a proper environmental balance is sustained. Apart from judicious utilization of the available resources there is need to reduce pollution & other malevolent footprints. The sensitive and vigilant collaboration amongst relevant stakeholders including Industry, Government, Academia and Communities is required to pave the way for an all-inclusive, humane & environmentally sustainable development. Implementing the initiatives including Smart Cities Mission that reduces the strain on the conventional mediums & incorporating the use of the relevant modern tools, techniques and solutions that ensures environmental sustainability is the need of the hour.

Confederation of Indian Industry (CII) has been playing a vital role in supporting various affairs related to the sustainable & holistic development.

In this context,, I am pleased to announce that CII is organizing Environ Expo 2018 from 6th to 8th December 2018 at the Auto Cluster Exhibition Centre, Pune, India under the Chairmanship of Mr M S Unnikrishnan, Managing Director & CEO, Thermax Ltd.

It is a dedicated exhibition on Clean Energy, Environment Protection, e-Mobility & Waste Management. A one day CII Green Conclave - focused Conference emphasizing on Sustainable growth will be co-located alongside the show.

CII Environ Expo 2018 is being actively supported by leading entities including National Environmental Engineering Research Institute (CSIR-NEERI), Indian Green Building Council (IGBC), Gujarat Knowledge Application & Facilitation Centre (GKAFC) and Solar Power Developers Association (SPDA).

Switching drugs from prescription (Rx) to over-the-counter (OTC) status is a commercial strategy that has been growing in popularity. Successful switches are as much an art as a science, and it has become increasingly apparent that switch teams must revise their best practices in strategy, marketing, sales, clinical research, regulatory affairs, medical writing, labeling, and packaging if they are to effectively collaborate and lead an Rx product through the switch to OTC.

Now in its fifth consecutive year, ExL’s Rx-to-OTC Switch Summit is the most advanced thought leadership event experts can attend to discuss all aspects of a switch, from the NDA process to the final over-the-counter product; analyze current trends, and prepare for future switches. Whether you are exploring your chances of tapping into the very lucrative OTC marketplace or are an expert in the field, this conference will provide detailed presentations, intensive case studies and collaborative panel discussions relevant to your interests.

The Antibody Society is an international, non-profit association representing individuals and organizations involved in antibody-related research and development. Our members serve as the Scientific Advisors for the Antibody Engineering & Therapeutics (US) and the Antibody Engineering & Therapeutics Europe conferences. To provide additional opportunities for education and networking, we contribute scientific content and financial support for other conferences that cover topics relevant to antibody R&D, and are hosted by non-profit organizations. We research and analyze data on targeted therapeutics developed by the biopharmaceutical industry, and distribute our results and opinion via the Society’s website, presentations and publications. The Society also engages with government and international agencies on matters of importance to the antibody community.

We invite all interested participants across the globe to attend 10th Annual Congress on Drug Design & Analytical Techniques during September 03-04, 2018 in UAE, Dubai which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. Drug Formulation 2018  is a specially designed cluster Pharmaceutical and Medicinal Chemistry Conference. The main theme of this  Pharma conferences is “On-going Research & Inventing a Formula for Developing Drug and Analysis” which covers a wide range of critically important sessions.

Working under the theme "Inventing formula for Drug Development and Analytical Techniques" this unique international conference will opportunity to reach the largest assemblage of participants from the Pharmaceutical community to gather and share their insights and convey recent developments in the field of generic drug research and current challenges and possibilities in modeling a new drug and breakthroughs in drug development, Generic drug safety, Novel trends and advanced strategies involving Formulation research. This is a true forum where ideas and discussion is driven by the participants and interaction with peers and others leads to fruitful outcomes.

Drug Formulation 2018 is a 2-day event offering the Exhibition, at venue to showcase the new and emerging technologies and have wider sessions involving Keynote presentation, Oral, YRF ( student presentation), poster, e-poster presentations. World-renowned speakers and eminent delegates across the globe attending the conference, to share their valuable presentation on the most recent and advanced techniques, developments, and the newest updates are the prominent features of the conference.

ME Conferences invites all the participants across the globe to attend 20th world conference on pharmaceutical chemistry and Drug Design during September 03-05, 2018 at Dubai which includes innovative keynote presentations, lectures, Poster presentations and workshops or symposiums. Pharm Chem 2018 Congress is a specially designed gathering Pharmaceutical and Medicinal Chemistry Conference. The main theme of this Pharma conferences is “Exceeding the vision in drug and pharmaceutical chemistry” which covers a wide range of critically important sessions.

Up until now, attention has been highly fixated on ‘Medical cannabis’. Meanwhile Pharmaceutical Cannabinoids have made incredible progress, now academia and industry must unite to advance further. By providing the inaugural International Cannabinoid-Derived Pharmaceuticals Summit, we have created this opportunity.

Issues include formulating unique compounds that achieve required responses, that can be delivered effectively. Many also still face problems designing reliable clinical trials in a frequently changing regulatory environment. We’ll be sharing and discussing these issues in depth with industry leaders such as Adi Zulloff-Shani of Therapix and Catherine Jacobson of Tilray.

ConferenceSeries is a renowned organization that organizes highly notable conferences throughout the globe. Currently we are bringing forth “23rd International Conference on Pharmaceutical Biotechnology” (Pharma Biotech 2018) scheduled to be held during December 10-11, 2018 at Rome, Italy. The conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Pharmaceutical sciences and Biotechnology.

ConferenceSeries organizes a conference series of 1000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Virtue Insight is delighted to invite you to attend the 13th Biosimilars Congregation 2018 conference, to be held on 11th December 2018 in Mumbai, India. 13th Biosimilars Congregation 2018 brings together scientists, researchers and CROs from around the world. The biosimilars market is owned to experience an exponential growth over the coming few years. Many biologics products are making their entry in the pharma market and experiencing a notable rise in their usage over the conventional medications.

At 13th Biosimilars Congregation 2018 meet your target audiences from around the world focused on learning about biologics and biosimilars. This conference would be your single best opportunity to reach the largest assemblage of participants from the biologics and biosimilars community

Immerse Yourself In The Latest Us Regulatory Policy At This Critical Time In Scientific Innovation

Connect with FDA, CMS, and CDRH Leaders to Learn How Regulatory Changes Will Impact You, Your Organization, and the Biopharma Industry

These technologies enable remote monitoring, more personalized diagnosis and treatments. While the FDA’s position has been encouraging, healthcare providers are conscious of pending stringent guidelines that will have undoubtable impact on this add-on feature, whereas drug and device developers are not used to the fast pace of technology innovation. It is clear that connectivity certainly casts doubts and risks in the cybersecurity and compliance world, particularly with patient data privacy.

Building on an already established Device Series, the inaugural Connected Devices: Cybersecurity & Compliance Summit 2018 will provide an unparalleled platform for industry stakeholders to share lessons learned, discuss common challenges and devise standard industry guidelines.

Welcome to the Inaugural Microbiome Gut-Brain Axis Summit

Thank you for joining microbiome and CNS thought leaders at the Microbiome Gut-Brain Axis Summit 2017  – a three-day event dedicated to help large pharma, biotech, and academic researchers unlock the potential of the gut-brain axis in demonstrating disease causation and translating these findings into safe and effective therapeutic candidates.

Download the full programme to see how leading researchers are revealing the secrets of the gut-brain axis to help answer some of the greatest scientific challenges of the 21st century.

DDL provides an annual forum for scientists, academics, clinicians, regulatory and industry specialists involved in developing medicines for inhalation.

DDL2018 will have five themed sessions each with a combination of invited and submitted lectures given by experts in the field of inhalation and students working to advance respiratory science.

The 3rd New Product Planning Summit will bring together cross-functional stakeholders from product development teams at biopharma, medical device, and large pharmaceutical companies and discuss key strategies to effectively commercialize a new product. Join our esteemed speaking faculty as they explore the differences in roles and responsibilities of new product planning professionals based on company size and culture, and share valuable insights and best practices to employ at different stages of a product’s life cycle.

Advances in Inflammatory Bowel Diseases is dedicated to the interests of the entire community of IBD patients and is designed to meet the educational needs of all healthcare professionals who treat and manage patients with inflammatory bowel diseases.

We believe the growth and success of Advances in IBD comes from our dedication to offering a comprehensive scientific agenda that is clinically relevant, scientifically state of the art, and the most effective in addressing the educational needs of attendees, while always remaining focused on the goal of enhancing the lives of patients with inflammatory bowel diseases.

ME Conferences organizes 300+ conferences, 500+workshops and 200+symposiums on Clinical, Medicine, Pharma and Science & Technology.

With the coordination of the Organizing Committee, we are gratified to framework the program for the 13th International Conference on Allergy and Clinical Immunology, December, 2018 in Abu Dhabi, UAE. Our conference includes a well-proportioned cast of speakers, covering both generous and precise topics. Our conference intents to provide allergists, immunologists, cellular and molecular biologists, biochemists, biotechnologists, microbiologists, paediatricians, physicians, specialists, doctors, technologist, professors, students and anyone professionally involved in Allergy and Immunology Care with an opportunity to learn about the multiplicity of the Immune system, discuss interventional procedures and reactions, look at sophisticated therapies and their efficacy and efficiency in the treatment of various immune disorders, and comprehend practical constraints in improving healthcare. The Allergy 2018 will be organized encompassing the theme “Emerging Therapeutics for allergy and immune disorders". Allergy 2018 is comprehended of 18 tracks designed to offer widespread sessions that directs current issues in Allergy & Immunological research affairs.

ME Conferences organizes 300+ conferences, 500+workshops and 200+symposiums on Clinical, Medicine, Pharma and Science & Technology. Immunology events are every year across UK, Europe, Asia, Middle East, Australia and USA that support immunology conferences from 1000 more scientific societies and Publishes 100+ open access journals which contain over 30000 eminent personalities, reputed scientists as editorial board members. Allergy 2018 comes under Immunology medical conferences.

With the coordination of the Organizing Committee, we are gratified to framework the program for the 13th International Conference on Allergy and Clinical Immunology, December, 2018 in Abu Dhabi, UAE. Our conference includes a well-proportioned cast of speakers, covering both generous and precise topics. Our conference intents to provide allergists, immunologists, cellular and molecular biologists, biochemists, biotechnologists, microbiologists, paediatricians, physicians, specialists, doctors, technologist, professors, students and anyone professionally involved in Allergy and Immunology Care with an opportunity to learn about the multiplicity of the Immune system, discuss interventional procedures and reactions, look at sophisticated therapies and their efficacy and efficiency in the treatment of various immune disorders, and comprehend practical constraints in improving healthcare. The Allergy 2018 will be organized encompassing the theme “Emerging Therapeutics for allergy and immune disorders". Allergy 2018 is comprehended of 18 tracks designed to offer widespread sessions that directs current issues in Allergy & Immunological research affairs.

There are regulatory mechanisms to accelerate the review and/or approval of treatments for patients with serious diseases. Accelerated Approval, Breakthrough Therapy Designation, Fast Track Designation, Priority Review, and Orphan Drug Act are designed to expedite treatment availability for medications that provide an increased benefit over existing treatments.

What does this really mean for sponsors and patients? Patients could have improved or novel treatments available sooner. While sponsors have successful tracks to obtain increased communication and collaboration with the FDA, enabling precise decision-making.

These regulatory options are available to ensure that FDA resources are allocated to review and approve therapies as soon as the benefits justify any risks. ExL’s 2nd Innovative Regulatory Pathways will serve as a platform to discuss and compare the current regulatory pathways that allow for earlier attention to drugs that have promise in treating serious or life-threatening conditions.

ICBE brings together researchers who are using quantitative approaches to advance the understanding and application of molecular biology.

SMi is proud to present their 11th annual European conference and exhibition, within the Pre-Filled Syringes series: Pre-Filled Syringes & Injectable Drug Devices Europe. The event will take place on the 16th-17th of January 2019, in London.

Building on the sell-out success of the 10th annual event in 2018, the 11th annual conference promises to be even bigger, with the addition of a new section to the agenda on Injectable Drug Devices.

SMi is proud to present the return of their 11th annual Social Media in the Pharmaceutical Industry conference to London on the 21st - 22nd January 2019.

The conference will be discussing how to leverage social media platforms to develop a robust digital strategy and discuss the latest challenges and techniques in the field of social pharma.

The pharmaceutical microbiology industry has seen many changes during the progression into the 21st century. With advances in rapid microbiological methods, revisions being made to regulations in the industry, enhanced knowledge of the human microbiome, and novel testing methods, this industry is ever expanding. In fact, the value of the rapid microbiology testing market is expected to reach USD 6.2 Billion by 2022, expanding at a CAGR of 7.3% from 2016 to 2022.

Hear insights from key stakeholders including biosimilar and innovator pharmaceutical manufacturers, payers, providers and patient advocates addressing everything from navigating impending regulations, determining optimal pricing models, accelerating market access strategies and executing strategic, long term decisions to mitigate risk and build for success.

Join CBI’s 14th Biosimilars Summit and explore the current global climate for biosimilars, evaluate competition and benchmark with industry peers on how to navigate the changing regulations and landscape of the biosimilars market.

Now in its sixth year, CBI’s Reimbursement and Contracting provides a platform for bio/pharmaceutical manufacturers looking to unravel complexities associated with reimbursement, pricing strategies and commercial contracting. As pricing pressures and competition continue to mount, reimbursement, pricing and contract teams must navigate evolving landscapes to developing competitive pricing strategies. Join experts to discuss the latest on patient access, reform, ACOs, IDNs, health insurance exchanges, Medicare Part D, 340B and much more!

Conducting regulatory reviews of novel therapies in a timely manner is essential to improve public health concerns and ensure medical needs are met. There are regulatory mechanisms in place worldwide to accelerate the delivery of treatments for patients with serious diseases or unmet medical needs.

Many regulatory authorities throughout the world have implemented pathways that aim to expedite the submission or the review of products that cater to these medical needs. Understanding how to utilize expedited regulatory paths like Breakthrough Therapy Designation, PRIME, and Sakigake Designation is imperative to make an informed decision about the best ways to accelerate drug development.

These regulatory options are available to ensure regulatory bodies allocated the resources to review and approve therapies as soon as the benefits justify any risks. ExL’s 2nd Innovative Regulatory Pathways will serve as a platform to discuss and compare the current regulatory pathways that allow for earlier attention to drugs that have promise in treating serious or life-threatening conditions.

The 3rd annual Patients as Partners EU is the only conference in Europe that demonstrates how to involve patients throughout the entire medicines development life cycle to drive greater efficiencies in clinical research.

Patients as Partners EU is co-produced with industry, patient advocacy and government to establish a well-rounded program that addresses the needs of all stakeholders seeking to implement and advance patient involvement across the entire clinical development continuum.

Each session puts ideas into action and demonstrates the what, where, when and how behind the topic. The sessions demonstrate how these insights were used to co-create solutions with patients and measure the impact of those initiatives.

IAM’s third annual Pharma & Biotech IP event will provide cutting-edge legal and strategic insights to help practitioners safeguard and exploit their crucial life sciences assets.

SMi presents its 13th annual Parallel Trade conference, taking place in London on the 5th-6th of February 2019. As the only parallel trade conference in Europe, this event provides the perfect platform for industry experts from both sides of the coin to come together and share perspectives on the practice of parallel trade.

The 2019 event will hold a particular place of significance due to Brexit and the UK officially leaving the EU on the 29th of March 2019. As such, the UK will no longer be part of the EU free market; hence, having a significant impact on parallel trade.

Furthermore, the FMD (Falsified Medicines Directive) will be coming into effect in February 2019. This conference will give companies affected the perfect opportunity to discuss and consider the impact that the FMD implementation will have on their practices and on the market.